Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment of epilepsy and...
FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the treatment of...
AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it from its rivals, after...
With in-depth features on mobile health, clinical trials and Brexit, and the future of patient-reported outcomes, as well as interviews with Amicus...
Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead drug candidate, NEOD001, had both missed the mark.
It's the end of another week and there's really been one story that has dominated the headlines – Takeda’s potential takeover of Shire. It should...
Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over the next five years,...
Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the clinic to undergo the lengthy...
Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small number of US...
MSD is once again flexing Keytruda’s muscles, this time unveiling that the anti-PD-1 drug has excelled in combination with chemotherapy in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches